Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Alessandra Schiavo

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive)Elena Biagini, Maria Alessandra Schiavo
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Non-dilated left ventricular cardiomyopathy: beyond morphology, towards diagnostic precision]Vanda Parisi, Raffaello Ditaranto, Ferdinando Pasquale, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Left Ventricular Ring-like Pattern: The Arrhythmic Tale of a Scarred HeartVanda Parisi, Claudio Bergami, Ferdinando Pasquale, et al.
International Journal of Molecular Sciences|September 14, 2024
When Paying Attention Pays Back: Missense Mutation c.1006G>A p. (Val336Ile) in <i>PRKAG2</i> Gene Causing Left Ventricular Hypertrophy and Conduction Abnormalities in a Caucasian Patient: Case Report and Literature ReviewEmanuele Micaglio, Lara Tondi, Sara Benedetti, et al.
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[State of the art and projects of the Italian Fabry Disease Cardiovascular Registry]Elena Biagini, Giuseppe Limongelli, Vanda Parisi, et al.
European Heart Journal. Cardiovascular Imaging|September 25, 2025
Sex-specific prognostic thresholds of left ventricular hypertrophy in Fabry diseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
Circulation. Genomic and Precision Medicine|February 6, 2026
Cardiovascular Morbidity and Mortality in Fabry DiseaseEmanuele Monda, Athanasios Bakalakos, Annamaria Del Franco, et al.
European Heart Journal. Cardiovascular Imaging|October 28, 2025
Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance StudyPietro Francia, Giulio Falasconi, Maria Beatrice Musumeci, et al.
International Journal of Cardiology|January 24, 2025
A single RBM20 missense variant is a potential contributor to dilated cardiomyopathy and/or isolated left ventricular dilatation in the Emilia Romagna region of ItalySamuela Carigi, Giulia Olivucci, Carlotta Pia Cristalli, et al.
International Journal of Cardiology|March 31, 2025
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progressionVanda Parisi, Raffaello Ditaranto, Nevio Taglieri, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
European Heart Journal Supplements : Journal of the European Society of Cardiology|May 8, 2026
The ODYSSEY-HCM and MAPLE-HCM studies: the role of cardiac myosin inhibitors in hypertrophic cardiomyopathy (obstructive and non-obstructive)Elena Biagini, Maria Alessandra Schiavo
Giornale Italiano Di Cardiologia (2006)|February 25, 2026
[Non-dilated left ventricular cardiomyopathy: beyond morphology, towards diagnostic precision]Vanda Parisi, Raffaello Ditaranto, Ferdinando Pasquale, et al.
Journal of Cardiovascular Development and Disease|July 25, 2025
Left Ventricular Ring-like Pattern: The Arrhythmic Tale of a Scarred HeartVanda Parisi, Claudio Bergami, Ferdinando Pasquale, et al.
International Journal of Molecular Sciences|September 14, 2024
When Paying Attention Pays Back: Missense Mutation c.1006G>A p. (Val336Ile) in <i>PRKAG2</i> Gene Causing Left Ventricular Hypertrophy and Conduction Abnormalities in a Caucasian Patient: Case Report and Literature ReviewEmanuele Micaglio, Lara Tondi, Sara Benedetti, et al.
Giornale Italiano Di Cardiologia (2006)|August 27, 2025
[State of the art and projects of the Italian Fabry Disease Cardiovascular Registry]Elena Biagini, Giuseppe Limongelli, Vanda Parisi, et al.
European Heart Journal. Cardiovascular Imaging|September 25, 2025
Sex-specific prognostic thresholds of left ventricular hypertrophy in Fabry diseaseMaria Chiara Meucci, Rosa Lillo, Annamaria Del Franco, et al.
Circulation. Genomic and Precision Medicine|February 6, 2026
Cardiovascular Morbidity and Mortality in Fabry DiseaseEmanuele Monda, Athanasios Bakalakos, Annamaria Del Franco, et al.
European Heart Journal. Cardiovascular Imaging|October 28, 2025
Scar Architecture as a Structural Biomarker of Ventricular Arrhythmias and Sudden Cardiac Death in Patients with Hypertrophic Cardiomyopathy: a Cardiac Magnetic Resonance StudyPietro Francia, Giulio Falasconi, Maria Beatrice Musumeci, et al.
International Journal of Cardiology|January 24, 2025
A single RBM20 missense variant is a potential contributor to dilated cardiomyopathy and/or isolated left ventricular dilatation in the Emilia Romagna region of ItalySamuela Carigi, Giulia Olivucci, Carlotta Pia Cristalli, et al.
International Journal of Cardiology|March 31, 2025
Electrocardiogram evolution in Anderson-Fabry disease patients during follow-up in relation to specific treatment and cardiac disease progressionVanda Parisi, Raffaello Ditaranto, Nevio Taglieri, et al.
Pageof 2